You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rifampicin-susceptible-TB

Showing 1 - 25 of 1,976
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB) Trial in Cape Town (BVL-GSK098 9mg, Ethionamide 250mg,

Not yet recruiting
  • Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
  • BVL-GSK098 9mg
  • +3 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
Jul 26, 2022

HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)

Recruiting
  • HIV/AIDS
  • Tuberculosis, Pulmonary
  • Biktarvy®
  • TLD- fixed-drug combination single tablet
  • Durban, KwaZulu-Natal, South Africa
    CAPRISA Springfield Clinical Research Site
Mar 14, 2022

Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)

Recruiting
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Jan 24, 2023

Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)

Not yet recruiting
  • Tuberculosis
  • Human Immunodeficiency Virus
  • Optimised rifamycin
  • (no location specified)
Oct 8, 2022

Rifampicin Susceptible Pulmonary Tuberculosis Trial in Cape Town (RESP301, HRZE)

Not yet recruiting
  • Rifampicin Susceptible Pulmonary Tuberculosis
  • Cape Town, Bellville, South Africa
    TASK Clinical Research Centre
Sep 11, 2023

Pulmonary Tuberculosis Trial in Cape Town (Meropenem 6g IV over 6 hours, Ertapenem 1g IM, Meropenem 3g IV)

Completed
  • Pulmonary Tuberculosis
  • Meropenem 6g IV over 6 hours
  • +9 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 31, 2023

Tuberculosis, Pulmonary Trial in Cape Town (Sanfetrinem Cilexetil, Amoxicillin/clavulanic acid, Rifampicin)

Recruiting
  • Tuberculosis, Pulmonary
  • Sanfetrinem Cilexetil
  • +2 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 19, 2022

Rifampicin-resistant Tuberculosis Trial in Beijing (Sudapyridine, Bedaquiline)

Enrolling by invitation
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
    Beijing Chest Hospital affiliated to Capital Medical University
Apr 21, 2023

Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for

Not yet recruiting
  • Tuberculosis
  • Rifampicin Resistant Tuberculosis
  • Pretomanid
  • Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
  • Rio De Janeiro, Brazil
  • +6 more
Oct 18, 2022

Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)

Not yet recruiting
  • Tuberculous Meningitis
  • High dose rifampicin (25mg/kg)
  • +8 more
  • Chennai, Tamil Nadu, India
    ICMR- National Institute for Research in Tuberculosis
Jun 15, 2023

Pulmonary Tuberculosis Trial (GSK3036656, BTZ-043, Bedaquiline (B))

Not yet recruiting
  • Pulmonary Tuberculosis
  • (no location specified)
Oct 27, 2023

Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)

Recruiting
  • Tuberculosis, Pulmonary
  • Linköping, Sweden
    Linköping University Hospital
Aug 19, 2021

Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

Active, not recruiting
  • Tuberculosis
  • +4 more
  • Bedaquiline Oral Tablet
  • +7 more
  • Port Elizabeth, Eastern Cape, South Africa
  • +1 more
Oct 20, 2022

Tuberculosis, Multidrug-Resistant Trial (Amikacin)

Not yet recruiting
  • Tuberculosis, Multidrug-Resistant
  • (no location specified)
Sep 23, 2022

Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

Not yet recruiting
  • Pulmonary Tuberculosis
  • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
  • +3 more
  • (no location specified)
Jul 25, 2023

Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • HIV
  • Port-au-Prince, Haiti
  • +1 more
Nov 11, 2022

Pediatric HIV Infection, Tuberculosis Infection Trial (rifampicin)

Not yet recruiting
  • Pediatric HIV Infection
  • Tuberculosis Infection
  • (no location specified)
Sep 26, 2021

Tuberculosis, Diagnoses Disease Trial (Truenat TB platform/TB assays)

Recruiting
  • Tuberculosis
  • Diagnoses Disease
  • Truenat TB platform/TB assays
  • Manhiça, Vila Da Manhiça, Mozambique
  • +3 more
Nov 30, 2022

Pulmonary TB Trial in South Africa (Delamanid + Bedaquiline + OPC-167832 10 mg, Delamanid + Bedaquiline + OPC-167832 30 mg,

Recruiting
  • Pulmonary TB
  • Delamanid + Bedaquiline + OPC-167832 10 mg
  • +3 more
  • Tembisa, Gauteng, South Africa
  • +7 more
Jun 30, 2022

Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug

Completed
  • Pulmonary Tuberculoses
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +1 more
Aug 9, 2022

or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV

Not yet recruiting
  • Tuberculosis
  • Pulmonary
    • Kampala, Uganda
    • +3 more
    Jul 12, 2021

    Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)

    Recruiting
    • Tuberculosis
    • +2 more
    • Johannesburg, Gauteng, South Africa
      Tembisa Clinical Research Centre-The Aurum Institute
    Jun 8, 2022

    Innovating(IN) Shorter(S), All- Oral, Precised(P),

    Not yet recruiting
    • Multidrug Resistant Tuberculosis
    • This is a non-intervention observational study.
    • Guiyang, Guizhou, China
    • +4 more
    Oct 5, 2021

    Tuberculosis Trial in Cape Town (Meropenem Injection, Amoxicillin Clavulanate, Pyrazinamide)

    Completed
    • Tuberculosis
    • Meropenem Injection
    • +4 more
    • Cape Town, Western Cape, South Africa
      TASK Clinical Research Centre
    Jan 24, 2022

    Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis, Tuberculosis Trial in Niamey (6EH³R³Z, 6EHRZ)

    Recruiting
    • Multidrug-resistant Tuberculosis
    • +3 more
    • Niamey, Niger
      Damien Foundation
    Oct 29, 2021